{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:31:58Z","timestamp":1740547918487,"version":"3.38.0"},"reference-count":118,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["203.PPSP.6171388"],"award-info":[{"award-number":["203.PPSP.6171388"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The clinical application of cellular immunotherapy in hepatocellular carcinoma (HCC) is impeded by the lack of a cell surface target frequently expressed in HCC cells and with minimal presence in normal tissues to reduce on-target, off-tumor toxicity. To address this, an in silico multomics analysis was conducted to identify an optimal therapeutic target in HCC. A longlist of genes (n\u2009=\u200912,948) expressed in HCCs according to The Human Protein Atlas database were examined. Eight genes were shortlisted to identify one with the highest expression in HCCs, without being shed into circulation, and with restrictive expression profile in other normal human tissues. A total of eight genes were shortlisted and subsequently ranked according to the combination of their transcript and protein expression levels in HCC cases (n\u2009=\u2009791) derived from four independent datasets. TM4SF4 was the top-ranked target with the highest expression in HCCs. TM4SF4 showed more favorable expression profile with significantly lower expression in normal human tissues but more highly expressed in HCC compared with seven other common HCC therapeutic targets. Furthermore, scRNA-seq and immunohistochemistry datasets showed that TM4SF4 was absent in immune cell populations but highly expressed in the bile duct canaliculi of hepatocytes, regions inaccessible to immune cells. In scRNA-seq dataset of HCCs, <jats:italic>TM4SF4<\/jats:italic> expression was positively associated with mitochondrial components and oxidative phosphorylation Gene Ontologies in HCC cells (n\u2009=\u200915,787 cells), suggesting its potential roles in mitochondrial-mediated oncogenic effects in HCC. Taken together, TM4SF4 is proposed as a promising cell surface target in HCC due to its high expression in HCC cells with restricted expression profile in non-cancerous tissues, and association with HCC oncogenic pathways.<\/jats:p>","DOI":"10.1371\/journal.pone.0307048","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:37:58Z","timestamp":1740508678000},"page":"e0307048","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiomics in silico analysis identifies TM4SF4 as a cell surface target in hepatocellular carcinoma"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-6202","authenticated-orcid":true,"given":"Kah Keng","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzina Sheikh","family":"Ab. Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"3","key":"pone.0307048.ref001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"pone.0307048.ref002","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma","volume":"77","author":"R Donne","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"pone.0307048.ref003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"JM Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 2","key":"pone.0307048.ref004","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.21037\/jgo.2020.02.08","article-title":"Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management","volume":"12","author":"H Samant","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"pone.0307048.ref005","first-page":"225","article-title":"Liver mesenchymal neoplasms: something old, something new","volume":"54","author":"K Algashaamy","year":"2022","journal-title":"Pathology (Phila)"},{"issue":"11","key":"pone.0307048.ref006","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/jnci\/djab079","article-title":"The mortality and overall survival trends of primary liver cancer in the United States","volume":"113","author":"YT Lee","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"pone.0307048.ref007","doi-asserted-by":"crossref","first-page":"100232","DOI":"10.1016\/j.jhepr.2021.100232","article-title":"Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation","volume":"3","author":"HCC-UK\/BASL\/NCRAS Partnership Steering Group","year":"2021","journal-title":"JHEP Rep"},{"issue":"4","key":"pone.0307048.ref008","first-page":"2379","article-title":"Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis","volume":"13","author":"A Facciorusso","year":"2021","journal-title":"Am J Transl Res"},{"issue":"9","key":"pone.0307048.ref009","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/gutjnl-2020-320716","article-title":"Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma","volume":"70","author":"R Shang","year":"2021","journal-title":"Gut"},{"issue":"4","key":"pone.0307048.ref010","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"AL Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"pone.0307048.ref011","doi-asserted-by":"crossref","first-page":"109484","DOI":"10.1016\/j.ejrad.2020.109484","article-title":"Radiological response to nivolumab in patients with hepatocellular carcinoma: a multicenter analysis of real-life practice","volume":"135","author":"J Rimola","year":"2021","journal-title":"Eur J Radiol"},{"issue":"10-11","key":"pone.0307048.ref012","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41417-020-00259-4","article-title":"Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma","volume":"28","author":"J Guo","year":"2021","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"pone.0307048.ref013","first-page":"14","article-title":"The role of glypican-3 in regulating Wnt in hepatocellular carcinomas","volume":"1","author":"W Gao","year":"2011","journal-title":"Cancer Rep"},{"key":"pone.0307048.ref014","doi-asserted-by":"crossref","first-page":"691391","DOI":"10.3389\/fgene.2021.691391","article-title":"Mechanisms and clinical trials of hepatocellular carcinoma immunotherapy","volume":"12","author":"SL Huang","year":"2021","journal-title":"Front Genet"},{"issue":"1","key":"pone.0307048.ref015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2006.10.185","article-title":"Glypicans are differentially expressed during patterning and neurogenesis of early mouse brain","volume":"352","author":"G Luxardi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"pone.0307048.ref016","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/med.21455","article-title":"Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment","volume":"38","author":"F Zhou","year":"2018","journal-title":"Med Res Rev"},{"key":"pone.0307048.ref017","first-page":"1","article-title":"Preprint: Single-cell genomics reveals region-specific developmental trajectories underlying neuronal diversity in the prenatal human hypothalamus","author":"BR Herb","year":"2021","journal-title":"bioRxiv"},{"issue":"11","key":"pone.0307048.ref018","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00262-017-2034-7","article-title":"The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity","volume":"66","author":"FC Thistlethwaite","year":"2017","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"pone.0307048.ref019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"RA Morgan","year":"2013","journal-title":"J Immunother"},{"issue":"26","key":"pone.0307048.ref020","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"JN Brudno","year":"2016","journal-title":"Blood"},{"issue":"6","key":"pone.0307048.ref021","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/ijc.24941","article-title":"Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo","volume":"126","author":"SI Zittermann","year":"2010","journal-title":"Int J Cancer"},{"issue":"9","key":"pone.0307048.ref022","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/ijc.25549","article-title":"Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro","volume":"128","author":"M Feng","year":"2011","journal-title":"Int J Cancer"},{"issue":"4","key":"pone.0307048.ref023","doi-asserted-by":"crossref","first-page":"e001875","DOI":"10.1136\/jitc-2020-001875","article-title":"Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in hepatocellular carcinoma","volume":"9","author":"L Sun","year":"2021","journal-title":"J ImmunoTher Cancer"},{"issue":"6220","key":"pone.0307048.ref024","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"M Uhlen","year":"2015","journal-title":"Science"},{"issue":"6352","key":"pone.0307048.ref025","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"M Uhlen","year":"2017","journal-title":"Science"},{"issue":"609","key":"pone.0307048.ref026","doi-asserted-by":"crossref","first-page":"eaaz0274","DOI":"10.1126\/scisignal.aaz0274","article-title":"The human secretome","volume":"12","author":"M Uhlen","year":"2019","journal-title":"Sci Signal"},{"issue":"6340","key":"pone.0307048.ref027","doi-asserted-by":"crossref","first-page":"eaal3321","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"PJ Thul","year":"2017","journal-title":"Science"},{"issue":"6482","key":"pone.0307048.ref028","doi-asserted-by":"crossref","first-page":"eaay5947","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"E Sjostedt","year":"2020","journal-title":"Science"},{"issue":"D1","key":"pone.0307048.ref029","doi-asserted-by":"crossref","first-page":"D892","DOI":"10.1093\/nar\/gkaa1054","article-title":"FANTOM enters 20th year: expansion of transcriptomic atlases and functional annotation of non-coding RNAs","volume":"49","author":"I Abugessaisa","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"7493","key":"pone.0307048.ref030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature13182","article-title":"A promoter-level mammalian expression atlas","volume":"507","author":"FANTOM Consortium and the RIKEN PMI and CLST (DGT)","year":"2014","journal-title":"Nature"},{"issue":"6235","key":"pone.0307048.ref031","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","author":"GTEx Consortium","year":"2015","journal-title":"Science"},{"issue":"6","key":"pone.0307048.ref032","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"GTEx Consortium","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"pone.0307048.ref033","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"pone.0307048.ref034","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cell.2018.03.042","article-title":"The Cancer Genome Atlas: Creating Lasting Value beyond Its Data","volume":"173","author":"C Hutter","year":"2018","journal-title":"Cell"},{"issue":"9","key":"pone.0307048.ref035","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1021\/acs.jproteome.5b00500","article-title":"State of the Human Proteome in 2014\/2015 As Viewed through PeptideAtlas: Enhancing Accuracy and Coverage through the AtlasProphet","volume":"14","author":"EW Deutsch","year":"2015","journal-title":"J Proteome Res"},{"issue":"12","key":"pone.0307048.ref036","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1021\/acs.jproteome.7b00467","article-title":"The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays","volume":"16","author":"JM Schwenk","year":"2017","journal-title":"J Proteome Res"},{"issue":"5","key":"pone.0307048.ref037","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"E Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"pone.0307048.ref038","first-page":"pl1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"J Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"7747","key":"pone.0307048.ref039","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Chinese Human Proteome Project (CNHPP) Consortium","year":"2019","journal-title":"Nature"},{"issue":"24","key":"pone.0307048.ref040","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","article-title":"A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients","volume":"70","author":"S Roessler","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"pone.0307048.ref041","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/hep.31412","article-title":"Intratumoral gammadelta T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4\/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma","volume":"73","author":"N Zhao","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"pone.0307048.ref042","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma","volume":"179","author":"Q Gao","year":"2019","journal-title":"Cell"},{"key":"pone.0307048.ref043","doi-asserted-by":"crossref","first-page":"107897","DOI":"10.1016\/j.compbiolchem.2023.107897","article-title":"Integrated transcriptomics and proteomics data analysis identifies CDH17 as a key cell surface target in colorectal cancer","volume":"105","author":"KK Wong","year":"2023","journal-title":"Comput Biol Chem"},{"issue":"1","key":"pone.0307048.ref044","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2020.08.022","article-title":"Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies","volume":"183","author":"KR Parker","year":"2020","journal-title":"Cell"},{"key":"pone.0307048.ref045","doi-asserted-by":"crossref","first-page":"836452","DOI":"10.3389\/fonc.2022.836452","article-title":"Immunotherapy Associated Neurotoxicity in Pediatric Oncology","volume":"12","author":"H Shalabi","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"pone.0307048.ref046","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1097\/HS9.0000000000000533","article-title":"Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells","volume":"5","author":"P Karschnia","year":"2021","journal-title":"Hemasphere"},{"issue":"4","key":"pone.0307048.ref047","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"RA Morgan","year":"2010","journal-title":"Mol Ther"},{"issue":"6","key":"pone.0307048.ref048","doi-asserted-by":"crossref","first-page":"102619","DOI":"10.1016\/j.isci.2021.102619","article-title":"Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors","volume":"24","author":"AL Portillo","year":"2021","journal-title":"iScience"},{"key":"pone.0307048.ref049","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fphys.2018.00916","article-title":"Metabolic Network-Based Identification and Prioritization of Anticancer Targets Based on Expression Data in Hepatocellular Carcinoma","volume":"9","author":"G Bidkhori","year":"2018","journal-title":"Front Physiol"},{"issue":"1","key":"pone.0307048.ref050","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1038\/s41598-017-04520-z","article-title":"A Comprehensive Mouse Transcriptomic BodyMap across 17 Tissues by RNA-seq","volume":"7","author":"B Li","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0307048.ref051","doi-asserted-by":"crossref","first-page":"bau012","DOI":"10.1093\/database\/bau012","article-title":"COMPARTMENTS: unification and visualization of protein subcellular localization evidence","author":"JX Binder","year":"2014","journal-title":"Database (Oxford)"},{"issue":"3","key":"pone.0307048.ref052","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/omi.2015.0168","article-title":"Geneanalytics: an integrative gene set analysis tool for next generation sequencing, RNAseq and microarray data","volume":"20","author":"S Ben-Ari Fuchs","year":"2016","journal-title":"OMICS"},{"issue":"3","key":"pone.0307048.ref053","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.33249","article-title":"Novel insights into the function of CD24: A driving force in cancer","volume":"148","author":"P Altevogt","year":"2021","journal-title":"Int J Cancer"},{"issue":"1","key":"pone.0307048.ref054","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1096\/fj.201901834R","article-title":"MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1\/CD24\/Src pathway","volume":"34","author":"P Zhang","year":"2020","journal-title":"FASEB J"},{"issue":"7","key":"pone.0307048.ref055","doi-asserted-by":"crossref","first-page":"e1440169","DOI":"10.1080\/2162402X.2018.1440169","article-title":"CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial","volume":"7","author":"Y Wang","year":"2018","journal-title":"Oncoimmunology"},{"issue":"4","key":"pone.0307048.ref056","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/15384047.2021.1916381","article-title":"The role of CD133 in hepatocellular carcinoma","volume":"22","author":"F Liu","year":"2021","journal-title":"Cancer Biol Ther"},{"key":"pone.0307048.ref057","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fcell.2019.00233","article-title":"Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy","volume":"7","author":"RY Zhang","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"pone.0307048.ref058","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1021\/acsabm.1c00177","article-title":"CD147 monoclonal antibody targeted reduction-responsive camptothecin polyphosphoester nanomedicine for drug delivery in hepatocellular carcinoma cells","volume":"4","author":"H Tian","year":"2021","journal-title":"ACS Appl Bio Mater"},{"issue":"3","key":"pone.0307048.ref059","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5009\/gnl210162","article-title":"Circulating cancer stem cells expressing EpCAM\/CD90 in hepatocellular carcinoma: a pilot study for predicting tumor recurrence after living donor liver transplantation","volume":"16","author":"HS Hwang","year":"2022","journal-title":"Gut Liver"},{"issue":"2","key":"pone.0307048.ref060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00262-013-1497-4","article-title":"An EpCAM\/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression","volume":"63","author":"P Zhang","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"pone.0307048.ref061","doi-asserted-by":"crossref","first-page":"546586","DOI":"10.3389\/fonc.2021.546586","article-title":"Bispecific c-Met\/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular Carcinoma","volume":"11","author":"W Jiang","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0307048.ref062","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/med.21738","article-title":"Targeting hepatocyte growth factor\/c-mesenchymal-epithelial transition factor axis in hepatocellular carcinoma: Rationale and therapeutic strategies","volume":"41","author":"J Yu","year":"2021","journal-title":"Med Res Rev"},{"issue":"4","key":"pone.0307048.ref063","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mc.23389","article-title":"Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1\/miR-4726-5p\/MUC1 pathway","volume":"61","author":"Q Tang","year":"2022","journal-title":"Mol Carcinog"},{"issue":"9","key":"pone.0307048.ref064","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2174\/1568009622666220317090552","article-title":"Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma","volume":"22","author":"AR Kumar","year":"2022","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"pone.0307048.ref065","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","article-title":"A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma","volume":"13","author":"Y Lu","year":"2022","journal-title":"Nat Commun"},{"issue":"7808","key":"pone.0307048.ref066","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2157-4","article-title":"Construction of a human cell landscape at single-cell level","volume":"581","author":"X Han","year":"2020","journal-title":"Nature"},{"issue":"5","key":"pone.0307048.ref067","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"R Satija","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"3","key":"pone.0307048.ref068","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/leu.2015.299","article-title":"FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas","volume":"30","author":"PJ Brown","year":"2016","journal-title":"Leukemia"},{"issue":"33","key":"pone.0307048.ref069","doi-asserted-by":"crossref","first-page":"52940","DOI":"10.18632\/oncotarget.9507","article-title":"FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures","volume":"7","author":"KK Wong","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"pone.0307048.ref070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13562-017-0407-9","article-title":"Towards the mode of action of Strobilanthes crispus through integrated computational and experimental analyses","volume":"26","author":"KK Wong","year":"2017","journal-title":"J Plant Biochem Biotechnol"},{"key":"pone.0307048.ref071","doi-asserted-by":"crossref","first-page":"675250","DOI":"10.3389\/fimmu.2021.675250","article-title":"CD3(+)CD4(+)gp130(+) T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients","volume":"12","author":"ND Mohd Shukri","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0307048.ref072","doi-asserted-by":"crossref","first-page":"819772","DOI":"10.3389\/fmolb.2022.819772","article-title":"IL-4\/IL-13 Axis in Allergic Rhinitis: Elevated Serum Cytokines Levels and Inverse Association With Tight Junction Molecules Expression","volume":"9","author":"SM Nur Husna","year":"2022","journal-title":"Front Mol Biosci"},{"key":"pone.0307048.ref073","doi-asserted-by":"crossref","first-page":"118026","DOI":"10.1016\/j.lfs.2020.118026","article-title":"Comparative transcriptomic profiling in HPV-associated cervical carcinogenesis: Implication of MHC class II and immunoglobulin heavy chain genes","volume":"256","author":"SD Balasubramaniam","year":"2020","journal-title":"Life Sci"},{"key":"pone.0307048.ref074","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ebiom.2018.08.024","article-title":"Cholangiopathies - Towards a molecular understanding","volume":"35","author":"PKH Tam","year":"2018","journal-title":"EBioMedicine"},{"issue":"W1","key":"pone.0307048.ref075","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Z Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0307048.ref076","doi-asserted-by":"crossref","first-page":"107746","DOI":"10.1016\/j.compbiolchem.2022.107746","article-title":"Comprehensive analysis of the large and small ribosomal proteins in breast cancer: Insights on proteomic and transcriptomic expression patterns, regulation, mutational landscape, and prognostic significance","volume":"100","author":"ALK Azevedo","year":"2022","journal-title":"Comput Biol Chem"},{"key":"pone.0307048.ref077","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocs.2022.101881","article-title":"Discovering biomarkers of hepatocellular carcinoma from single-cell RNA sequencing data by cooperative games on gene regulatory network","volume":"65","author":"Z Zhang","year":"2022","journal-title":"J Comput Sci"},{"key":"pone.0307048.ref078","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fmolb.2020.00202","article-title":"Role of transmembrane 4\u2009L Six family 1 in the development and progression of cancer","volume":"7","author":"F Fu","year":"2020","journal-title":"Front Mol Biosci"},{"key":"pone.0307048.ref079","doi-asserted-by":"crossref","first-page":"702510","DOI":"10.3389\/fonc.2021.702510","article-title":"Tetraspanins: Novel Molecular Regulators of Gastric Cancer","volume":"11","author":"Y Deng","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0307048.ref080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drudis.2020.10.022","article-title":"Tetraspanins: useful multifunction proteins for the possible design and development of small-molecule therapeutic tools","volume":"26","author":"JH Robert","year":"2021","journal-title":"Drug Discov Today"},{"issue":"8","key":"pone.0307048.ref081","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1110\/ps.9.8.1594","article-title":"The L6 membrane proteins--a new four-transmembrane superfamily","volume":"9","author":"MD Wright","year":"2000","journal-title":"Protein Sci"},{"issue":"4","key":"pone.0307048.ref082","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00430-020-00673-3","article-title":"Tetraspanins: integrating cell surface receptors to functional microdomains in homeostasis and disease","volume":"209","author":"D Kummer","year":"2020","journal-title":"Med Microbiol Immunol"},{"issue":"37","key":"pone.0307048.ref083","doi-asserted-by":"crossref","first-page":"21907","DOI":"10.1074\/jbc.270.37.21907","article-title":"A tetraspan membrane glycoprotein produced in the human intestinal epithelium and liver that can regulate cell density-dependent proliferation","volume":"270","author":"BM Wice","year":"1995","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0307048.ref084","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10620-013-2952-y","article-title":"Association of TM4SF4 with the human thiamine transporter-2 in intestinal epithelial cells","volume":"59","author":"VS Subramanian","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"1-2","key":"pone.0307048.ref085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0167-4781(01)00170-1","article-title":"Molecular cloning of a cDNA for rat TM4SF4, a homolog of human il-TMP (TM4SF4), and enhanced expression of the corresponding gene in regenerating rat liver(1)","author":"Z Liu","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"pone.0307048.ref086","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cels.2016.09.002","article-title":"A Single-Cell Transcriptome Atlas of the Human Pancreas","volume":"3","author":"MJ Muraro","year":"2016","journal-title":"Cell Syst"},{"issue":"2","key":"pone.0307048.ref087","doi-asserted-by":"crossref","first-page":"107904","DOI":"10.1016\/j.celrep.2020.107904","article-title":"ZIGIR, a Granule-Specific Zn(2+) Indicator, Reveals Human Islet alpha Cell Heterogeneity","volume":"32","author":"EH Ghazvini Zadeh","year":"2020","journal-title":"Cell Rep"},{"issue":"3","key":"pone.0307048.ref088","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/abbs\/gmr124","article-title":"Human tetraspanin transmembrane 4 superfamily member 4 or intestinal and liver tetraspan membrane protein is overexpressed in hepatocellular carcinoma and accelerates tumor cell growth","volume":"44","author":"Y Li","year":"2012","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"3","key":"pone.0307048.ref089","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/abbs\/gms115","article-title":"Adenovirus-mediated delivery of siRNA targeting TM4SF4 attenuated liver cancer cell growth in vitro and in vivo","volume":"45","author":"L Wang","year":"2013","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"8","key":"pone.0307048.ref090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/CAD.0000000000001326","article-title":"LncRNA ST8SIA6-AS1 facilitates hepatocellular carcinoma progression by governing miR-651-5p\/TM4SF4 axis","volume":"33","author":"Y Mou","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"1","key":"pone.0307048.ref091","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1038\/s41598-017-05280-6","article-title":"The integrated pathway of TGFbeta\/Snail with TNFalpha\/NFkappaB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis","volume":"7","author":"H Li","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0307048.ref092","first-page":"1009","article-title":"TYMS-TM4SF4 axis promotes the progression of colorectal cancer by EMT and upregulating stem cell marker","volume":"12","author":"F Zhang","year":"2022","journal-title":"Am J Cancer Res"},{"issue":"1","key":"pone.0307048.ref093","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/dna.2011.1264","article-title":"Overexpression of S100B, TM4SF4, and OLFM4 genes is correlated with liver metastasis in Taiwanese colorectal cancer patients","volume":"31","author":"MY Huang","year":"2012","journal-title":"DNA Cell Biol"},{"issue":"20","key":"pone.0307048.ref094","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.18632\/oncotarget.2450","article-title":"TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1","volume":"5","author":"SI Choi","year":"2014","journal-title":"Oncotarget"},{"issue":"60","key":"pone.0307048.ref095","doi-asserted-by":"crossref","first-page":"101284","DOI":"10.18632\/oncotarget.21021","article-title":"Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells","volume":"8","author":"SI Choi","year":"2017","journal-title":"Oncotarget"},{"issue":"68","key":"pone.0307048.ref096","doi-asserted-by":"crossref","first-page":"112647","DOI":"10.18632\/oncotarget.22636","article-title":"3D-cultivation of NSCLC cell lines induce gene expression alterations of key cancer-associated pathways and mimic in-vivo conditions","volume":"8","author":"G Gamerith","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0307048.ref097","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4143\/crt.2020.434","article-title":"TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis","volume":"53","author":"K Jung","year":"2021","journal-title":"Cancer Res Treat"},{"issue":"3","key":"pone.0307048.ref098","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.21037\/gs-21-151","article-title":"Identification of novel hub genes and lncRNAs related to the prognosis and progression of pancreatic cancer by microarray and integrated bioinformatics analysis","volume":"10","author":"X Liang","year":"2021","journal-title":"Gland Surg"},{"issue":"4","key":"pone.0307048.ref099","first-page":"1774","article-title":"Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer","volume":"53","author":"J Liu","year":"2018","journal-title":"Int J Oncol"},{"key":"pone.0307048.ref100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.mito.2020.10.004","article-title":"Complex IV - The regulatory center of mitochondrial oxidative phosphorylation","volume":"58","author":"B Kadenbach","year":"2021","journal-title":"Mitochondrion"},{"key":"pone.0307048.ref101","doi-asserted-by":"crossref","first-page":"6670579","DOI":"10.1155\/2021\/6670579","article-title":"The role of mitochondria in liver ischemia-reperfusion injury: from aspects of mitochondrial oxidative stress, mitochondrial fission, mitochondrial membrane permeable transport pore formation, mitophagy, and mitochondria-related protective measures","author":"H Zhang","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"pone.0307048.ref102","doi-asserted-by":"crossref","first-page":"105116","DOI":"10.1016\/j.compbiomed.2021.105116","article-title":"Computers and preventative diagnosis. A survey with bioinformatics examples of mitochondrial small open reading frame peptides as portents of a new generation of powerful biomarkers","volume":"140","author":"B Robson","year":"2021","journal-title":"Comput Biol Med"},{"issue":"1","key":"pone.0307048.ref103","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","article-title":"Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis","volume":"11","author":"P An","year":"2020","journal-title":"Nat Commun"},{"key":"pone.0307048.ref104","doi-asserted-by":"crossref","first-page":"104750","DOI":"10.1016\/j.yexmp.2022.104750","article-title":"Alcohol: basic and translational research; 15th annual Charles Lieber &1st Samuel French satellite symposium","volume":"126","author":"MG Neuman","year":"2022","journal-title":"Exp Mol Pathol"},{"issue":"8","key":"pone.0307048.ref105","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/cells10081901","article-title":"Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma","volume":"10","author":"HY Lee","year":"2021","journal-title":"Cells"},{"key":"pone.0307048.ref106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2015.03.001","article-title":"The mitochondria-plasma membrane contact site","volume":"35","author":"B Westermann","year":"2015","journal-title":"Curr Opin Cell Biol"},{"issue":"52","key":"pone.0307048.ref107","doi-asserted-by":"crossref","first-page":"43198","DOI":"10.1074\/jbc.M510279200","article-title":"Subplasmalemmal mitochondria modulate the activity of plasma membrane Ca2+-ATPases","volume":"280","author":"M Frieden","year":"2005","journal-title":"J Biol Chem"},{"issue":"6","key":"pone.0307048.ref108","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1021\/pr301166p","article-title":"The liver connexin32 interactome is a novel plasma membrane-mitochondrial signaling nexus","volume":"12","author":"SL Fowler","year":"2013","journal-title":"J Proteome Res"},{"key":"pone.0307048.ref109","first-page":"3683026","article-title":"Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells","author":"WA Poolsri","year":"2018","journal-title":"Biomed Res Int"},{"issue":"2","key":"pone.0307048.ref110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jhep.2006.08.011","article-title":"Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4","volume":"46","author":"J Qiu","year":"2007","journal-title":"J Hepatol"},{"issue":"3","key":"pone.0307048.ref111","doi-asserted-by":"crossref","first-page":"102151","DOI":"10.1016\/j.isci.2021.102151","article-title":"Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy","volume":"24","author":"E Wyler","year":"2021","journal-title":"iScience"},{"key":"pone.0307048.ref112","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-122015\/v2","article-title":"Bioinformatics analysis of expression profiling by high throughput sequencing for identification of potential key genes among SARS-CoV-2\/COVID 19","author":"BM Vastrad","year":"2021"},{"key":"pone.0307048.ref113","first-page":"2014625","article-title":"Classification and prognostic characteristics of hepatocellular carcinoma based on glycolysis cholesterol synthesis axis","author":"W Deng","year":"2022","journal-title":"J Oncol"},{"issue":"5","key":"pone.0307048.ref114","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"M Zhang","year":"2020","journal-title":"J Hepatol"},{"issue":"suppl_4","key":"pone.0307048.ref115","doi-asserted-by":"crossref","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"J Haanen","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"pone.0307048.ref116","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1159\/000516199","article-title":"Intrahepatic bile duct injury as a hepatic immune-related adverse event after immune-checkpoint inhibitor treatment","volume":"15","author":"A Murayama","year":"2021","journal-title":"Case Rep Gastroenterol"},{"key":"pone.0307048.ref117","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2020.01.006","article-title":"Pancreatic alpha-cells - The unsung heroes in islet function","volume":"103","author":"A Wendt","year":"2020","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"pone.0307048.ref118","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1038\/emm.2016.6","article-title":"Pancreatic regulation of glucose homeostasis","volume":"48","author":"PV Roder","year":"2016","journal-title":"Exp Mol Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:38:36Z","timestamp":1740508716000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307048"}},"subtitle":[],"editor":[{"given":"Mahmood S","family":"Choudhery","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":118,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0307048","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}